Canada Life
TTPH

Canada Life’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Canada Life’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-96
Closed -$9K – 2525
2016
Q1 		$9K Hold
96
– – ﹤0.01% 2413
2015
Q4 		$19K Hold
96
– – ﹤0.01% 2373
2015
Q3 		$14K Hold
96
– – ﹤0.01% 2366
2015
Q2 		$91K Hold
96
– – ﹤0.01% 1933
2015
Q1 		$70K Buy
+96
New +$72.1K ﹤0.01% 1986

Other funds holding TTPH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Canada Life's TTPH Position: Q2 2016 in Review

Canada Life sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2016, closing a stake of 96 shares — an estimated $9K sold.

Canada Life first reported a position in TTPH in Q1 2015 and held it in 5 quarters. The position peaked at $91K in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • Canada Life reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • Canada Life sold 96 Tetraphase Pharmaceuticals, Inc. shares in Q2 2016, an estimated $9K.
  • Canada Life first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 5 quarters.
  • Canada Life's Tetraphase Pharmaceuticals, Inc. position peaked at $91K in Q2 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2016.

Based on Canada Life's 13F filing for Q2 2016, filed 3 Aug 2016.